303 related articles for article (PubMed ID: 31921178)
1. PKM2: A Potential Regulator of Rheumatoid Arthritis via Glycolytic and Non-Glycolytic Pathways.
Xu D; Liang J; Lin J; Yu C
Front Immunol; 2019; 10():2919. PubMed ID: 31921178
[TBL] [Abstract][Full Text] [Related]
2. Assessment of disease activity in patients with rheumatoid arthritis using plasma tumour M2-pyruvate kinase test.
Ahn SS; Kim HM; Park Y
Front Immunol; 2022; 13():901555. PubMed ID: 36059477
[TBL] [Abstract][Full Text] [Related]
3. Sarsasapogenin, a principal active component absorbed into blood of total saponins of Anemarrhena, attenuates proliferation and invasion in rheumatoid arthritis fibroblast-like synoviocytes through downregulating PKM2 inhibited pathological glycolysis.
Dai Y; Liu P; Wen W; Li P; Yang C; Wang P; Xu S
Phytother Res; 2023 May; 37(5):1951-1967. PubMed ID: 36631974
[TBL] [Abstract][Full Text] [Related]
4. Upregulated PKM2 in Macrophages Exacerbates Experimental Arthritis via STAT1 Signaling.
Xu J; Jiang C; Wang X; Geng M; Peng Y; Guo Y; Wang S; Li X; Tao P; Zhang F; Han Y; Ning Q; Zhu W; Meng L; Lu S
J Immunol; 2020 Jul; 205(1):181-192. PubMed ID: 32503893
[TBL] [Abstract][Full Text] [Related]
5. Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis.
Zuo J; Tang J; Lu M; Zhou Z; Li Y; Tian H; Liu E; Gao B; Liu T; Shao P
Front Immunol; 2021; 12():779787. PubMed ID: 34899740
[TBL] [Abstract][Full Text] [Related]
6. Targeting glycolytic pathway in fibroblast-like synoviocytes for rheumatoid arthritis therapy: challenges and opportunities.
Li Q; Chen Y; Liu H; Tian Y; Yin G; Xie Q
Inflamm Res; 2023 Dec; 72(12):2155-2167. PubMed ID: 37940690
[TBL] [Abstract][Full Text] [Related]
7. Glycolysis and rheumatoid arthritis.
Chang X; Wei C
Int J Rheum Dis; 2011 Aug; 14(3):217-22. PubMed ID: 21816017
[TBL] [Abstract][Full Text] [Related]
8. [Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].
Seemayer CA; Distler O; Kuchen S; Müller-Ladner U; Michel BA; Neidhart M; Gay RE; Gay S
Z Rheumatol; 2001 Oct; 60(5):309-18. PubMed ID: 11759230
[TBL] [Abstract][Full Text] [Related]
9. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits Th17 differentiation via controlling PKM2-mediated glycolysis in rheumatoid arthritis.
Shen MY; Wang X; Di YX; Zhang MF; Tian FX; Qian FY; Jiang BP; Zhou LL
Immunopharmacol Immunotoxicol; 2022 Dec; 44(6):838-849. PubMed ID: 35657277
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells.
Canavan M; Marzaioli V; McGarry T; Bhargava V; Nagpal S; Veale DJ; Fearon U
Clin Exp Immunol; 2020 Nov; 202(2):226-238. PubMed ID: 32557565
[TBL] [Abstract][Full Text] [Related]
12. The role of dendritic cells and their immunometabolism in rheumatoid arthritis.
Suwa Y; Nagafuchi Y; Yamada S; Fujio K
Front Immunol; 2023; 14():1161148. PubMed ID: 37251399
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint.
Floudas A; Neto N; Marzaioli V; Murray K; Moran B; Monaghan MG; Low C; Mullan RH; Rao N; Krishna V; Nagpal S; Veale DJ; Fearon U
JCI Insight; 2020 Nov; 5(21):. PubMed ID: 33148884
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Sirt1 on energy metabolism and immune response in rheumatoid arthritis.
Wu YJ; Fang WJ; Pan S; Zhang SS; Li DF; Wang ZF; Chen WG; Yin Q; Zuo J
Int Immunopharmacol; 2021 Dec; 101(Pt A):108175. PubMed ID: 34689102
[TBL] [Abstract][Full Text] [Related]
15. PKM2 and cancer: The function of PKM2 beyond glycolysis.
Dong G; Mao Q; Xia W; Xu Y; Wang J; Xu L; Jiang F
Oncol Lett; 2016 Mar; 11(3):1980-1986. PubMed ID: 26998110
[TBL] [Abstract][Full Text] [Related]
16. Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase.
Mor I; Carlessi R; Ast T; Feinstein E; Kimchi A
Oncogene; 2012 Feb; 31(6):683-93. PubMed ID: 21725354
[TBL] [Abstract][Full Text] [Related]
17. The Role of PKM2 in the Regulation of Mitochondrial Function: Focus on Mitochondrial Metabolism, Oxidative Stress, Dynamic, and Apoptosis. PKM2 in Mitochondrial Function.
Gao J; Zhao Y; Li T; Gan X; Yu H
Oxid Med Cell Longev; 2022; 2022():7702681. PubMed ID: 35571239
[TBL] [Abstract][Full Text] [Related]
18. Identification of small molecule inhibitors of pyruvate kinase M2.
Vander Heiden MG; Christofk HR; Schuman E; Subtelny AO; Sharfi H; Harlow EE; Xian J; Cantley LC
Biochem Pharmacol; 2010 Apr; 79(8):1118-24. PubMed ID: 20005212
[TBL] [Abstract][Full Text] [Related]
19. HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways.
Bao C; Zhu S; Song K; He C
Cell Commun Signal; 2022 Aug; 20(1):132. PubMed ID: 36042519
[TBL] [Abstract][Full Text] [Related]
20. Aurora A-mediated pyruvate kinase M2 phosphorylation promotes biosynthesis with glycolytic metabolites and tumor cell cycle progression.
Jiang Y; Wang T; Sheng D; Han C; Xu T; Zhang P; You W; Fan W; Zhang Z; Jin T; Duan X; Yuan X; Liu X; Zhang K; Ruan K; Shi J; Guo J; Cheng A; Yang Z
J Biol Chem; 2022 Nov; 298(11):102561. PubMed ID: 36198360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
